KYSA-7
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KYSA-7, covering 2025-01-13 to 2025-01-13. Get the full timeline:
Most recent: Clinical Trial Update: KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis [Phase 2]